Preprothyrotropin-releasing hormone mRNA in the rat central gray is strongly and persistently induced during morphine withdrawal

Neuropeptides

Volumn 30, Issue 3, 1996, Pages 207-212

  Gahn, L G ^a   Sevarino, K A ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE PRECURSOR; MESSENGER RNA; MORPHINE; NALTREXONE; PLACEBO; PROTIRELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN REGION; CENTRAL GRAY MATTER; CONTROLLED STUDY; DRUG WITHDRAWAL; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029834273     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90065-7     Document Type: Article

References (14)

1. Wei E T. Enkephalin analogs and physical dependence. J Pharmacol Exp Ther 1989; 216: 12-18.
2. Bozarth M A, Wise R A. Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 1984; 224: 516-517.
3. Maldonado R, Stinus L, Gold L H, Koob G F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 1992; 261: 669-677.
4. Segerson T P, Hoefler H, Childers H et al. Localization of thyrotropin-releasing hormone prohormone messenger ribonucleic acid in rat brain by in situ hybridization. Endocrinology 1987; 121: 98-107.
5. Eskay R L, Long R T, Palkovits M. Localization of immunoreactive thyrotropin-releasing hormone in the lower brainstem of the rat. Brain Res 1983; 277: 159-162.
6. Lechan R M, Wu P, Jackson I M D. Immunocytochemical distribution in rat brain of putative peptides derived from thyrotropin-releasing hormone prohormone. Endocrinology 1987; 121: 1879-1891.
7. Sharif N A. Quantitative autoradiography of TRH receptors in discrete brain regions of different mammalian species. Ann NY Acad Sci 1989; 553: 147-175.
8. Bhargava H N. The effects of thyrotropin-releasing hormone on the central nervous system responses to chronic morphine administration. Psychopharmacology 1980; 68: 185-189.
9. Bhargava H N, Matwyshyn G A. Comparative effects of thyrotropin-releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome. Psychopharmacology 1985; 87: 141-146.
10. Bhargava H N. Dissociation of tolerance to the analgesic and hypothermic effects of morphine by using thyrotropin-releasing hormone. Life Sci 1981; 29: 1015-1020.
11. Rasmussen K, Beitner-Johnson D B, Krystal J H, Aghajanian G K, Nestler E J. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci 1990; 10: 2308-2317.
12. Lee S L, Sevarino K A. Molecular assays for rat thyrotropin-releasing hormone gene. Methods Neurosci 1991; 5: 34-52.
13. Rosen J B, Cain C J, Weiss S R B, Post R M. Alterations in mRNA of enkephalin, dynorphin and thyrotropin-releasing hormone during amygdala kindling: an in situ hybridization study. Mol Brain Res 1992; 15: 247-255.
14. Cheing B, Keay K A, Christie M J. Increased Fos-like immunoreactivity in the periaqueductal gray of anaesthetized rats during opiate withdrawal. Neurosci Lett 1995; 183: 79-82.